Article
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers.
Pathology - 1 Feb 2012
Hopper J L, Jenkins M A, Dowty J G, Dite G S, Apicella C, Keogh L, Win A K, Young J P, Buchanan D, Walsh M D, Rosty C, Baglietto L, Severi G, Phillips K A, Wong E M, Dobrovic A, Waring P, Winship I, Ramus S J, Giles G G, Southey M C
Abstract excerpt
Genes have been identified for which germline mutations are associated with high lifetime risks of breast, colorectal and other cancers. Identification of mutation carriers through genetic testing is important as it could help lower cancer incidence and mortality. The translation of genetic information into better health outcomes is expensive because of the costs of genetic counselling as well as laboratory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.